The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kenyon Lawrence A since year 2005.
The trader's CIK number is 1230484.
At the time of this reporting, Kenyon Lawrence A is the CEO, Pres, CFO, Treas & Secy of Outlook Therapeutics, Inc. .
(stock ticker symbol OTLK).
See this page for all insider trading activities at Outlook Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-07||OTLK||Outlook Therapeutics, Inc.||Buy||25,000||.90||22,375|
|2018-09-18||ONS||Outlook Therapeutics, Inc.||Sale||10,100||.87||8,807|
|2017-12-22||ONS||Outlook Therapeutics, Inc.||Sale||26,165||1.13||29,566|
|2010-03-03||PRX||Par Pharmaceutical Companies, Inc.||Sale||21,439||25.22||540,713|
|2010-03-03||PRX||Par Pharmaceutical Companies, Inc.||Option Ex||21,439||13.06||279,993|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kenyon Lawrence A (CEO, Pres, CFO, Treas & Secy of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.